Pathogenesis and clinical features
The basic clinical manifestations of malaria are directly caused by the massive lysis (destruction) of infected red blood cells. When red blood cells rupture, a new generation of merozoites is released into the bloodstream. It is important to note that some of these merozoites transform into gametocytes, which are sexual cells. These are of key epidemiological importance: when a mosquito bites an infected person, the gametocytes enter the insect's body, where they complete their development cycle.
The causative agent of falciparum malaria, Plasmodium falciparum, poses a particular danger. Infection with this species drastically alters the physical properties of erythrocytes, significantly increasing their adhesion (ability to stick) to the endothelium of blood vessels. As a result, the blood's thrombogenic potential rises sharply. The severity of falciparum malaria, including the development of the fatal cerebral form, directly depends on the severity of vascular thrombosis.
Biochemical targets (the plasmodium's "Achilles' heel")
The principle of drug therapy for malaria is based on targeting those metabolic processes of the parasite that differ significantly from biochemical reactions in the human body.
- Amino acid and hemoglobin metabolism. Plasmodia lack the ability to synthesize amino acids de novo. All necessary building materials are obtained by actively breaking down host hemoglobin. This process takes place in the parasite's digestive vacuole involving specific proteases. The breakdown of hemoglobin releases a toxic factor — ferriprotoporphyrin (a heme metabolite), which is lethal to the plasmodium itself. As a defense mechanism, the parasite neutralizes this toxin by polymerizing it into an absolutely safe crystalline pigment — hemozoin. Disrupting the crystallization of hemozoin is the main mechanism of action of a number of antimalarial drugs.
- Energy metabolism. Glycolysis serves as the primary source of energy for the pathogen. However, there is also a secondary pathway — redox reactions occurring in mitochondria with the mandatory participation of ubiquinone. This mitochondrial pathway is critically important for the parasite's survival as it ensures nucleotide synthesis.
Classification by clinical application
All drugs are divided into four main groups depending on which stage of the complex life cycle of the plasmodium they exert a cidal effect on.
- Hematoschizonticides (treatment of the erythrocytic stage). Their main target is the erythrocytic forms of plasmodia. The use of this group makes it possible to rapidly stop acute clinical manifestations of the disease. Drugs: chloroquine, quinine, mefloquine, artemisinin, atovaquone, sulfonamides, pyrimethamine, proguanil. This also includes antibacterial agents: doxycycline, tetracycline, and clindamycin.
- Histoschizonticides (relapse prevention). The target of these drugs is the hepatic cycle of plasmodium development, i.e., its tissue forms. Drugs: primaquine, pyrimethamine.
- Agents for individual chemoprophylaxis. Prescribed to prevent the development of the disease in a specific individual. They affect both pre-erythrocytic and erythrocytic forms. Drugs and combinations: mefloquine, doxycycline, as well as the combination regimens "atovaquone + proguanil", "atovaquone + doxycycline", or "chloroquine + proguanil".
- Gametocides (community chemoprophylaxis). Their target is gametes. The destruction of sexual forms prevents the transmission of infection to mosquitoes, thereby stopping the spread of malaria in the human population. Drugs: pyrimethamine, primaquine.
Classification by Mechanism of Action
For convenience of systematization and understanding of pharmacodynamics, all antimalarial drugs are divided into four groups based on their specific biochemical target in the parasite's body.
| Mechanism of action | Drugs |
|---|---|
| Disruption of heme metabolism | Chloroquine, quinine, mefloquine, artemisinin |
| Blockade of mitochondrial electron transport | Primaquine, atovaquone |
| Inhibition of protein translation | Doxycycline, tetracycline, clindamycin |
| Blockade of folate metabolism | Sulfonamides, pyrimethamine, proguanil |
Briefly: answers to topical questions
What side effects are characteristic of quinine?
Quinine is characterized by a specific complex of poisoning symptoms known as "cinchonism". This complex includes tinnitus, deafness, headache, as well as nausea, vomiting, and various visual disturbances. In addition, the drug has pronounced cardiotoxicity, which manifests as arrhythmias and QT interval prolongation on the electrocardiogram.
Which antimalarial drugs are contraindicated in pregnancy?
The source indicates pregnancy as a contraindication for the use of chloroquine.
What stages does the life cycle of the malaria parasite include in the human body?
In the human body, the life cycle of the malaria parasite includes asexual reproduction, consisting of exoerythrocytic schizogony in liver cells and erythrocytic schizogony. The developmental process begins with the penetration of sporozoites and the formation of tissue merozoites. Then the parasite goes through the stages of trophozoites and schizonts in erythrocytes with the formation of erythrocytic merozoites, after which gametogony begins with the formation of gametocytes.
Which species of malaria parasites cause disease in humans?
Four main species of malaria parasites parasitize humans and cause disease. These include:
- Plasmodium falciparum (Plasmodium falciparum) is the causative agent of falciparum malaria.
- Plasmodium vivax (Plasmodium vivax) is the causative agent of vivax malaria.
- Plasmodium ovale (Plasmodium ovale) is the causative agent of ovale malaria.
- Plasmodium malariae (Plasmodium malariae) is the causative agent of quartan malaria.
To memorize drugs that disrupt heme metabolism, use the mnemonic: "My Aunt Can Cook" (Mefloquine, Artemisinin, Chloroquine, Cinchona alkaloid/Quinine).
Class and exam questions
Why is malignant tertian malaria more severe than other forms?
The causative agent of malignant tertian malaria (Plasmodium falciparum) increases erythrocyte adhesion to the endothelium. This causes vascular thrombosis, which can lead to severe complications, including cerebral malaria.
How does the plasmodium protect itself against toxic hemoglobin breakdown products?
The breakdown of hemoglobin produces toxic ferriprotoporphyrin. The plasmodium neutralizes it by polymerizing it into safe hemozoin crystals.
Which drugs are used to prevent the transmission of malaria to mosquitoes?
Gametocides such as primaquine and pyrimethamine are used for this purpose. They destroy the sexual forms of the parasite (gametes) in human blood.
Why are antibiotics, such as doxycycline, prescribed for malaria?
Antibiotics (doxycycline, tetracycline, clindamycin) act as hematoschizonticides. Their mechanism consists in inhibiting protein translation in the plasmodium.
What else to study on this topic
- Mechanism of merozoite transformation into gametocytes
- Role of proteases in the plasmodium digestive vacuole
- Significance of ubiquinone in parasite nucleotide synthesis
- Features of the hepatic cycle of plasmodium development
- Pharmacodynamics of the atovaquone + proguanil combination
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Antimalarial drugs" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Drugs for protozoan infections" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.